LFCR logo

LFCR
Lifecore Biomedical Inc

645
Mkt Cap
$317.34M
Volume
240,511.00
52W High
$8.85
52W Low
$4.76
PE Ratio
-6.46
LFCR Fundamentals
Price
$8.42
Prev Close
$8.47
Open
$8.55
50D MA
$7.33
Beta
1.80
Avg. Volume
160,598.42
EPS (Annual)
-$1.27
P/B
-29.94
Rev/Employee
$317,406.40
Loading...
Loading...
News
all
press releases
734,533 Shares in Lifecore Biomedical, Inc. $LFCR Bought by Grizzlyrock Capital LLC
Grizzlyrock Capital LLC purchased a new stake in shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
22NW LP Sells 1,490,981 Shares of Lifecore Biomedical, Inc. $LFCR
22NW LP lowered its position in Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) by 84.9% in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned...
MarketBeat·11d ago
News Placeholder
Halper Sadeh LLC Encourages Lifecore Biomedical, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) breached their fiduciary duties to shareholders. If...
Business Wire·12d ago
News Placeholder
Q4 Earnings Forecast for LFCR Issued By Barrington Research
Lifecore Biomedical, Inc. (NASDAQ:LFCR - Free Report) - Equities researchers at Barrington Research issued their Q4 2025 earnings per share (EPS) estimates for Lifecore Biomedical in a research...
MarketBeat·1mo ago
News Placeholder
Lifecore Biomedical (NASDAQ:LFCR) Releases Earnings Results, Beats Estimates By $0.01 EPS
Lifecore Biomedical (NASDAQ:LFCR - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.29) earnings per share (EPS) for the quarter, beating the consensus...
MarketBeat·1mo ago
News Placeholder
Lifecore Biomedical (LFCR) Reports Q1 Loss, Beats Revenue Estimates
Lifecore Biomedical (LFCR) delivered earnings and revenue surprises of +3.33% and +16.60%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings Miss Estimates
Harmony Biosciences (HRMY) delivered earnings and revenue surprises of -5.43% and +4.59%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Lifecore Biomedical (LFCR) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Lifecore Biomedical (LFCR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·3mo ago
News Placeholder
Lifecore Biomedical (LFCR) Soars 10.8%: Is Further Upside Left in the Stock?
Lifecore Biomedical (LFCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Zacks·3mo ago
News Placeholder
Lifecore Biomedical (LFCR) Reports Q4 Loss, Tops Revenue Estimates
Lifecore Biomedical (LFCR) delivered earnings and revenue surprises of -11.11% and +1.96%, respectively, for the quarter ended May 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
<
1
2
...
>

Latest LFCR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.